Healthcare Sector
Market Tracker
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
Expires | Type | Strike | OI | Change | Percent |
---|---|---|---|---|---|
09/19/2025 | CALL | $116.00 | 2,663 | +1,369 | +105.80% |
09/12/2025 | CALL | $117.00 | 1,088 | +1,003 | +1,180.00% |
09/05/2025 | CALL | $113.00 | 1,178 | +925 | +365.61% |
10/17/2025 | PUT | $100.00 | 1,253 | +501 | +66.62% |
09/05/2025 | PUT | $115.00 | 383 | +234 | +157.05% |
10/17/2025 | PUT | $105.00 | 1,304 | +157 | +13.69% |
10/10/2025 | PUT | $110.00 | 899 | -34 | -3.64% |
10/10/2025 | PUT | $105.00 | 853 | -35 | -3.94% |
09/05/2025 | PUT | $118.00 | 8 | -49 | -85.96% |
09/05/2025 | CALL | $114.00 | 505 | -73 | -12.63% |
09/19/2025 | PUT | $110.00 | 2,161 | -74 | -3.31% |
09/19/2025 | CALL | $115.00 | 4,076 | -77 | -1.85% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
Name | Pct Held | Shares | Total |
---|---|---|---|
Vanguard Total Stock Market Index Fund | 3.05% | 38.12M | 2.91B |
Income Fund of America Inc | 2.70% | 33.74M | 2.58B |
Vanguard 500 Index Fund | 2.32% | 28.99M | 2.21B |
Dodge & Cox Stock Fund | 2.02% | 25.19M | 1.92B |
Washington Mutual Investors Fund | 1.57% | 19.64M | 1.5B |
American Balanced Fund | 1.37% | 17.14M | 1.31B |
American Mutual Fund Inc | 1.33% | 16.67M | 1.27B |
Invesco ETF Tr-Invesco QQQ Tr, Series 1 ETF | 1.31% | 16.4M | 1.25B |
Fidelity 500 Index Fund | 1.10% | 13.75M | 1.05B |
SPDR S&P 500 ETF Trust | 1.08% | 13.5M | 1.03B |
Australia Acute Respiratory Distress Syndrome Market Growth and Company Report 2025-2033 Featuring Silence Therapeutics, Gilead Sciences, Terumo, Getinge, Livanova, Medtronic, Fresenius, Nipro, Pfizer
09/04 11:00 am
GlobeNewswire Inc.
Read morePharming Group appoints Kenneth Lynard as Chief Financial Officer
09/02 01:00 am
GlobeNewswire Inc.
Read moreGildea's Kite Pharma Just Acquired Interius—$350 Million Move Shakes Up Cancer Therapy
08/21 11:45 am
Benzinga
Read moreLigand to Participate in September Investor Conferences
08/19 04:00 pm
GlobeNewswire Inc.
Read moreMacroGenics Revenue Doubles in Q2
08/14 04:21 pm
The Motley Fool
Read moreKymera Revenue Drops 55 Percent in Q2
08/11 07:28 am
The Motley Fool
Read moreTango (TNGX) Q2 Revenue Drops 52%
08/05 08:25 pm
The Motley Fool
Read moreIDEAYA (IDYA) Q2 Net Loss Improves 27%
08/05 04:23 pm
The Motley Fool
Read moreMCL1 Inhibitor Drugs Clinical Trials & Market Opportunity Report 2025: Over 12 ML1 Inhibitor Drugs In Clinical Trials
08/05 04:28 am
GlobeNewswire Inc.
Read moreGilead's Newly Approved HIV Prevention Drug Poised To Add Billions To Future Sales
07/25 12:12 pm
Benzinga
Read moreINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD
07/06 10:00 am
GlobeNewswire Inc.
Read moreWhy Gilead Scinces Stock Tumbled on Tuesday
06/10 05:22 pm
The Motley Fool
Read more2 Stocks, 100%+ Combined Gains - All From Spotting Mispricing Before the Crowd
06/08 03:45 am
Investing.com
Read moreNurix Therapeutics to Host a Webcast Conference Call to Discuss Data from the Ongoing Phase 1 Clinical Trial of Bexobrutideg (NX-5948) Being Presented at the 30th European Hematology Association Congress (EHA2025)
06/06 07:00 am
GlobeNewswire Inc.
Read moreXilio Therapeutics Announces Closing of $50.0 Million Public Offering
06/05 06:38 pm
GlobeNewswire Inc.
Read morePenicillin Market Research Report 2025 - Global $12.5+ Bn Trends, Opportunities, and Forecasts, 2020-2030F
05/29 10:58 am
GlobeNewswire Inc.
Read moreMerus annonce ses résultats financiers pour le premier trimestre 2025 et fait le point sur ses activités
05/09 10:46 am
GlobeNewswire Inc.
Read moreNurix Therapeutics Presents Data at the AACR 2025 Annual Meeting Highlighting the Transformative Potential of Its Proprietary DEL-AI Platform Leveraging Machine Learning to Speed the Discovery of Novel Drugs
04/28 04:00 pm
GlobeNewswire Inc.
Read moreGilead Cancer Drug Combined With Merck's Drug Effective In Difficult To Treat Type Of Breast Cancer
04/21 02:49 pm
Benzinga
Read more2 High-Yielding ETFs Retirees Can Safely Build Their Portfolios Around
04/17 05:45 am
The Motley Fool
Read more2 Top Dividend Stocks That Could Set You Up for Life
04/09 07:00 am
The Motley Fool
Read moreIs Vertex Pharmaceuticals Stock a Buy?
04/08 09:45 am
The Motley Fool
Read moreMinimal Residual Disease Testing Market Forecast Report, 2025-2030 - Precision Medicine and Early Relapse Detection Drive MRD Testing Demand Worldwide
04/08 04:48 am
GlobeNewswire Inc.
Read more3 Stocks Leading Healthcare’s Comeback as Wall Street Turns Defensive
04/02 12:14 pm
Investing.com
Read morePharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed
03/21 12:31 pm
Benzinga
Read moreBispecific Antibody Market Opportunity, Drug Dosage, Patent, Price, Sales & Clinical Trials Insight 2030: New Report Highlights 600+ Bispecific Antibodies in Clinical Trials Worldwide
03/12 08:48 am
GlobeNewswire Inc.
Read moreThe Top Nasdaq-100 Stock in 2025 Has Nothing to Do With Artificial Intelligence (AI)
03/11 04:20 am
The Motley Fool
Read moreNon-Small Cell Lung Cancer Market Set for Significant Growth Across the 7MM During the Study Period (2025-2034) Due to the Rising Novel Therapeutic Options | DelveInsight
02/26 02:00 pm
GlobeNewswire Inc.
Read moreQuestex’s Fierce Pharma Unveils the Conference Program for the Inaugural Fierce Pharma Engage, Over 100 Speakers Confirmed to Deliver Unparalleled Education
02/24 11:00 am
GlobeNewswire Inc.
Read moreWhy Gilead Sciences Stock Is Jumping Today
02/12 01:21 pm
The Motley Fool
Read moreGilead Sciences Beats Q4 EPS Forecast
02/11 05:40 pm
The Motley Fool
Read more3 Fabulous Dividend Stocks to Buy in February
02/09 03:30 pm
The Motley Fool
Read moreThese 2 Dividend Stocks Are Absolute Bargains Right Now
02/08 09:30 am
The Motley Fool
Read more3 Top AI-Powered Biotech Stocks to Buy in February
02/06 10:45 am
The Motley Fool
Read moreGlobal Pharma & Biotech CRM Software Market To Surpass Valuation of US$ 20.0 Billion by 2033 | Astute Analytica
01/17 04:30 am
GlobeNewswire Inc.
Read moreObesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference
01/09 03:12 pm
Benzinga
Read moreNUT Midline Carcinoma Treatment Market Research Report 2023-2024 & 2034: Market Forecast by Treatment, Route of Administration, and End-User Across 5 Regions and 17+ Countries
01/09 11:53 am
GlobeNewswire Inc.
Read moreGalapagos Unveils 2025 Split To Accelerate Innovation, Sharpen Strategic Focus
01/08 03:07 pm
Benzinga
Read moreGalapagos wil aandeelhouderswaarde ontgrendelen met voornemen tot splitsing in twee beursgenoteerde entiteiten
01/08 02:30 am
GlobeNewswire Inc.
Read moreBurkitt Lymphoma Global Clinical Trials Review 2024: Clinical Trials by Region, Country, Trial Status, Trial Phase, Sponsor Type and End Point Status
12/23 01:44 pm
GlobeNewswire Inc.
Read moreCancer Monoclonal Antibodies Market to Grow at a 18.4% CAGR through 2031 | SkyQuest Technology
12/09 08:10 am
Benzinga
Read moreCoccidioidomycosis Drugs Market to Reach US$ 634.3 Million by 2034, Expanding at a CAGR of 4.9% | Fact.MR Report
12/04 08:00 am
GlobeNewswire Inc.
Read morePersonalized Medicines Market to Surpass Valuation of USD 1352.81 Billion by 2031 | SkyQuest Technology
11/26 08:30 pm
Benzinga
Read morePersonalized Medicines Market to Surpass Valuation of USD 1352.81 Billion by 2031 | SkyQuest Technology
11/26 08:30 pm
GlobeNewswire Inc.
Read moreNurix Therapeutics Presents Preclinical Data from Two Autoimmune and Inflammatory Disease Programs, NX-5948 and GS-6791, at ACR Convergence 2024
11/17 11:30 am
GlobeNewswire Inc.
Read moreGilead Unveils Long-Term Data From Seladelpar In Patients With Rare Liver Disease
11/15 03:14 pm
Benzinga
Read more3 Spectacular High-Yield Dividend Stocks to Buy in November
11/10 10:30 am
The Motley Fool
Read moreMerus annonce ses résultats financiers pour le troisième trimestre 2024 et fait le point sur ses activités
11/02 06:18 am
GlobeNewswire Inc.
Read more